"A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncologyMedicines that can rev up the immune system against tumors have reshaped expectations of what cancer treatment can accomplish. Their success has hit limits, however."
https://www.biopharmadive.com/news/cancer-immunotherapy-decade-keytruda-opdivo-pd1-oncology/725774/
- Forums
- ASX - By Stock
- Industry news
"A decade of cancer immunotherapy: Keytruda, Opdivo and the...
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
-0.050(3.17%) |
Mkt cap ! $259.9M |
Open | High | Low | Value | Volume |
$1.58 | $1.59 | $1.51 | $174.6K | 113.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2372 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 141 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2372 | 1.525 |
2 | 14459 | 1.520 |
1 | 660 | 1.515 |
1 | 11000 | 1.505 |
2 | 10030 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 141 | 1 |
1.620 | 2192 | 2 |
1.630 | 6499 | 2 |
1.640 | 4440 | 2 |
1.660 | 20000 | 1 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online